A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer
Clinical trial NCT04623333 · UNKNOWN
Trial details
- NCT number
- NCT04623333
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2022-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.